NT-proBNP is not elevated in patients with obstructive sleep apnoea

Summary Background N-terminal pro-brain natriuretic peptide (NT-ProBNP) has emerged as an important marker of cardiac stress and may reflect the severity of underlying cardiac dysfunction, which is thought to be associated with obstructive sleep apnoea syndrome (OSAS). Methods This study evaluated t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2008-01, Vol.102 (1), p.134-142
Hauptverfasser: Hübner, Ralf-Harto, El Mokhtari, Nour Eddine, Freitag, Sandra, Rausche, Tim, Göder, Robert, Tiroke, Andreas, Lins, Markus, Simon, Rüdiger, Bewig, Burkhard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue 1
container_start_page 134
container_title Respiratory medicine
container_volume 102
creator Hübner, Ralf-Harto
El Mokhtari, Nour Eddine
Freitag, Sandra
Rausche, Tim
Göder, Robert
Tiroke, Andreas
Lins, Markus
Simon, Rüdiger
Bewig, Burkhard
description Summary Background N-terminal pro-brain natriuretic peptide (NT-ProBNP) has emerged as an important marker of cardiac stress and may reflect the severity of underlying cardiac dysfunction, which is thought to be associated with obstructive sleep apnoea syndrome (OSAS). Methods This study evaluated the plasma concentration of NT-ProBNP in 60 consecutive patients (median age 55.7 years, median body mass index (BMI) 31.8) who were referred to a sleep laboratory with a suspicion of OSAS. Each subject underwent measurement of morning NT-ProBNP plasma levels, polysomnography and echocardiography. Patients were treated with nasal continuous or bilevel positive airway pressure ventilation (nCPAP/BIPAP) or without mechanical respiratory support, depending on clinical symptoms and results of polysomnography. Three months after treatment of OSAS 28 of the patients were reassessed for re-evaluation of NT-ProBNP and polysomnography. Results Low or high levels of NT-proBNP were not associated with AHI and other sleep related indices ( p >0.3). There was no correlation between NT-proBNP and AHI or other sleep related indices. In multiple regression analysis, NT-proBNP was significantly correlated with left ventricular ejection fraction, creatinine clearance and the presence of systemic arterial hypertension but not with AHI. Conclusions Our results show by a robust multiple regression analysis, that NT-pro BNP is not associated with OSAS and NT-pro BNP cannot be used as a sensitive marker for underlying cardiovascular abnormalities in patients with OSAS.
doi_str_mv 10.1016/j.rmed.2007.07.023
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70092364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0954611107003290</els_id><sourcerecordid>70092364</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-e8ecdea15fa6f394f8639d343e483a4f6ff43b97d3719c96461a4ca0f92de98f3</originalsourceid><addsrcrecordid>eNp9kltr3DAQhUVpabZJ_0AegiA0b97qZtmCUGiX3iAkhabPQiuPiDZe25HkDfn3ldilgTwUDehB34zOOQxCp5QsKaHy42YZttAtGSHNshTjr9CC1pxVnEjxGi2IqkUlKaVH6F2MG0KIEoK8RUe0aRXLZ4FW17fVFMYv17-wj3gYE4YediZBh_2AJ5M8DCniR5_u8LiOKcw2-R3g2ANM2EzDCOYEvXGmj_D-cB-jP9--3q5-VFc333-uPl9VtqY0VdCC7cDQ2hnpuBKulVx1XHAQLTfCSecEX6um4w1VVkkhqRHWEKdYB6p1_Bhd7OdmwQ8zxKS3PlroezPAOEfdZH-MS5HB8xfgZpzDkLVpSnhNhBSKZortKRvGGAM4PQW_NeEpQ7oErDe6BKxLwLoU47np7DB6Xpe3fy2HRDPw4QCYaE3vghmsj8-cysYUKYMu9xzkxHYego42Z22h8wFs0t3o_6_j04t22_vB5x_v4Qnis18dmSb6d1mFsgkkh8RZFvAXvZasrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035046491</pqid></control><display><type>article</type><title>NT-proBNP is not elevated in patients with obstructive sleep apnoea</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hübner, Ralf-Harto ; El Mokhtari, Nour Eddine ; Freitag, Sandra ; Rausche, Tim ; Göder, Robert ; Tiroke, Andreas ; Lins, Markus ; Simon, Rüdiger ; Bewig, Burkhard</creator><creatorcontrib>Hübner, Ralf-Harto ; El Mokhtari, Nour Eddine ; Freitag, Sandra ; Rausche, Tim ; Göder, Robert ; Tiroke, Andreas ; Lins, Markus ; Simon, Rüdiger ; Bewig, Burkhard</creatorcontrib><description>Summary Background N-terminal pro-brain natriuretic peptide (NT-ProBNP) has emerged as an important marker of cardiac stress and may reflect the severity of underlying cardiac dysfunction, which is thought to be associated with obstructive sleep apnoea syndrome (OSAS). Methods This study evaluated the plasma concentration of NT-ProBNP in 60 consecutive patients (median age 55.7 years, median body mass index (BMI) 31.8) who were referred to a sleep laboratory with a suspicion of OSAS. Each subject underwent measurement of morning NT-ProBNP plasma levels, polysomnography and echocardiography. Patients were treated with nasal continuous or bilevel positive airway pressure ventilation (nCPAP/BIPAP) or without mechanical respiratory support, depending on clinical symptoms and results of polysomnography. Three months after treatment of OSAS 28 of the patients were reassessed for re-evaluation of NT-ProBNP and polysomnography. Results Low or high levels of NT-proBNP were not associated with AHI and other sleep related indices ( p &gt;0.3). There was no correlation between NT-proBNP and AHI or other sleep related indices. In multiple regression analysis, NT-proBNP was significantly correlated with left ventricular ejection fraction, creatinine clearance and the presence of systemic arterial hypertension but not with AHI. Conclusions Our results show by a robust multiple regression analysis, that NT-pro BNP is not associated with OSAS and NT-pro BNP cannot be used as a sensitive marker for underlying cardiovascular abnormalities in patients with OSAS.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2007.07.023</identifier><identifier>PMID: 17892929</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adult ; Agreements ; Biological and medical sciences ; Biomarkers - blood ; BNP ; Body mass index ; Confidence intervals ; Female ; Females ; Heart disease ; Heart Diseases - complications ; Heart Diseases - metabolism ; Heart failure ; Hormone replacement therapy ; Humans ; Male ; Medical sciences ; Middle Aged ; Multivariate analysis ; Natriuretic Peptide, Brain - blood ; Natriuretic peptides ; NT-proBNP ; Obesity ; OSAS ; Peptide Fragments - blood ; Peptides ; Pneumology ; Polysomnography - methods ; Predictive Value of Tests ; Pulmonary/Respiratory ; Regression Analysis ; Respiratory system : syndromes and miscellaneous diseases ; Sleep ; Sleep apnea ; Sleep Apnea, Obstructive - blood ; Sleep Apnea, Obstructive - therapy</subject><ispartof>Respiratory medicine, 2008-01, Vol.102 (1), p.134-142</ispartof><rights>2007</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-e8ecdea15fa6f394f8639d343e483a4f6ff43b97d3719c96461a4ca0f92de98f3</citedby><cites>FETCH-LOGICAL-c511t-e8ecdea15fa6f394f8639d343e483a4f6ff43b97d3719c96461a4ca0f92de98f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0954611107003290$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19964903$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17892929$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hübner, Ralf-Harto</creatorcontrib><creatorcontrib>El Mokhtari, Nour Eddine</creatorcontrib><creatorcontrib>Freitag, Sandra</creatorcontrib><creatorcontrib>Rausche, Tim</creatorcontrib><creatorcontrib>Göder, Robert</creatorcontrib><creatorcontrib>Tiroke, Andreas</creatorcontrib><creatorcontrib>Lins, Markus</creatorcontrib><creatorcontrib>Simon, Rüdiger</creatorcontrib><creatorcontrib>Bewig, Burkhard</creatorcontrib><title>NT-proBNP is not elevated in patients with obstructive sleep apnoea</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Summary Background N-terminal pro-brain natriuretic peptide (NT-ProBNP) has emerged as an important marker of cardiac stress and may reflect the severity of underlying cardiac dysfunction, which is thought to be associated with obstructive sleep apnoea syndrome (OSAS). Methods This study evaluated the plasma concentration of NT-ProBNP in 60 consecutive patients (median age 55.7 years, median body mass index (BMI) 31.8) who were referred to a sleep laboratory with a suspicion of OSAS. Each subject underwent measurement of morning NT-ProBNP plasma levels, polysomnography and echocardiography. Patients were treated with nasal continuous or bilevel positive airway pressure ventilation (nCPAP/BIPAP) or without mechanical respiratory support, depending on clinical symptoms and results of polysomnography. Three months after treatment of OSAS 28 of the patients were reassessed for re-evaluation of NT-ProBNP and polysomnography. Results Low or high levels of NT-proBNP were not associated with AHI and other sleep related indices ( p &gt;0.3). There was no correlation between NT-proBNP and AHI or other sleep related indices. In multiple regression analysis, NT-proBNP was significantly correlated with left ventricular ejection fraction, creatinine clearance and the presence of systemic arterial hypertension but not with AHI. Conclusions Our results show by a robust multiple regression analysis, that NT-pro BNP is not associated with OSAS and NT-pro BNP cannot be used as a sensitive marker for underlying cardiovascular abnormalities in patients with OSAS.</description><subject>Adult</subject><subject>Agreements</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>BNP</subject><subject>Body mass index</subject><subject>Confidence intervals</subject><subject>Female</subject><subject>Females</subject><subject>Heart disease</subject><subject>Heart Diseases - complications</subject><subject>Heart Diseases - metabolism</subject><subject>Heart failure</subject><subject>Hormone replacement therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Natriuretic peptides</subject><subject>NT-proBNP</subject><subject>Obesity</subject><subject>OSAS</subject><subject>Peptide Fragments - blood</subject><subject>Peptides</subject><subject>Pneumology</subject><subject>Polysomnography - methods</subject><subject>Predictive Value of Tests</subject><subject>Pulmonary/Respiratory</subject><subject>Regression Analysis</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Sleep</subject><subject>Sleep apnea</subject><subject>Sleep Apnea, Obstructive - blood</subject><subject>Sleep Apnea, Obstructive - therapy</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kltr3DAQhUVpabZJ_0AegiA0b97qZtmCUGiX3iAkhabPQiuPiDZe25HkDfn3ldilgTwUDehB34zOOQxCp5QsKaHy42YZttAtGSHNshTjr9CC1pxVnEjxGi2IqkUlKaVH6F2MG0KIEoK8RUe0aRXLZ4FW17fVFMYv17-wj3gYE4YediZBh_2AJ5M8DCniR5_u8LiOKcw2-R3g2ANM2EzDCOYEvXGmj_D-cB-jP9--3q5-VFc333-uPl9VtqY0VdCC7cDQ2hnpuBKulVx1XHAQLTfCSecEX6um4w1VVkkhqRHWEKdYB6p1_Bhd7OdmwQ8zxKS3PlroezPAOEfdZH-MS5HB8xfgZpzDkLVpSnhNhBSKZortKRvGGAM4PQW_NeEpQ7oErDe6BKxLwLoU47np7DB6Xpe3fy2HRDPw4QCYaE3vghmsj8-cysYUKYMu9xzkxHYego42Z22h8wFs0t3o_6_j04t22_vB5x_v4Qnis18dmSb6d1mFsgkkh8RZFvAXvZasrQ</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Hübner, Ralf-Harto</creator><creator>El Mokhtari, Nour Eddine</creator><creator>Freitag, Sandra</creator><creator>Rausche, Tim</creator><creator>Göder, Robert</creator><creator>Tiroke, Andreas</creator><creator>Lins, Markus</creator><creator>Simon, Rüdiger</creator><creator>Bewig, Burkhard</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>NT-proBNP is not elevated in patients with obstructive sleep apnoea</title><author>Hübner, Ralf-Harto ; El Mokhtari, Nour Eddine ; Freitag, Sandra ; Rausche, Tim ; Göder, Robert ; Tiroke, Andreas ; Lins, Markus ; Simon, Rüdiger ; Bewig, Burkhard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-e8ecdea15fa6f394f8639d343e483a4f6ff43b97d3719c96461a4ca0f92de98f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Agreements</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>BNP</topic><topic>Body mass index</topic><topic>Confidence intervals</topic><topic>Female</topic><topic>Females</topic><topic>Heart disease</topic><topic>Heart Diseases - complications</topic><topic>Heart Diseases - metabolism</topic><topic>Heart failure</topic><topic>Hormone replacement therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Natriuretic peptides</topic><topic>NT-proBNP</topic><topic>Obesity</topic><topic>OSAS</topic><topic>Peptide Fragments - blood</topic><topic>Peptides</topic><topic>Pneumology</topic><topic>Polysomnography - methods</topic><topic>Predictive Value of Tests</topic><topic>Pulmonary/Respiratory</topic><topic>Regression Analysis</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Sleep</topic><topic>Sleep apnea</topic><topic>Sleep Apnea, Obstructive - blood</topic><topic>Sleep Apnea, Obstructive - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hübner, Ralf-Harto</creatorcontrib><creatorcontrib>El Mokhtari, Nour Eddine</creatorcontrib><creatorcontrib>Freitag, Sandra</creatorcontrib><creatorcontrib>Rausche, Tim</creatorcontrib><creatorcontrib>Göder, Robert</creatorcontrib><creatorcontrib>Tiroke, Andreas</creatorcontrib><creatorcontrib>Lins, Markus</creatorcontrib><creatorcontrib>Simon, Rüdiger</creatorcontrib><creatorcontrib>Bewig, Burkhard</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hübner, Ralf-Harto</au><au>El Mokhtari, Nour Eddine</au><au>Freitag, Sandra</au><au>Rausche, Tim</au><au>Göder, Robert</au><au>Tiroke, Andreas</au><au>Lins, Markus</au><au>Simon, Rüdiger</au><au>Bewig, Burkhard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NT-proBNP is not elevated in patients with obstructive sleep apnoea</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>102</volume><issue>1</issue><spage>134</spage><epage>142</epage><pages>134-142</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Summary Background N-terminal pro-brain natriuretic peptide (NT-ProBNP) has emerged as an important marker of cardiac stress and may reflect the severity of underlying cardiac dysfunction, which is thought to be associated with obstructive sleep apnoea syndrome (OSAS). Methods This study evaluated the plasma concentration of NT-ProBNP in 60 consecutive patients (median age 55.7 years, median body mass index (BMI) 31.8) who were referred to a sleep laboratory with a suspicion of OSAS. Each subject underwent measurement of morning NT-ProBNP plasma levels, polysomnography and echocardiography. Patients were treated with nasal continuous or bilevel positive airway pressure ventilation (nCPAP/BIPAP) or without mechanical respiratory support, depending on clinical symptoms and results of polysomnography. Three months after treatment of OSAS 28 of the patients were reassessed for re-evaluation of NT-ProBNP and polysomnography. Results Low or high levels of NT-proBNP were not associated with AHI and other sleep related indices ( p &gt;0.3). There was no correlation between NT-proBNP and AHI or other sleep related indices. In multiple regression analysis, NT-proBNP was significantly correlated with left ventricular ejection fraction, creatinine clearance and the presence of systemic arterial hypertension but not with AHI. Conclusions Our results show by a robust multiple regression analysis, that NT-pro BNP is not associated with OSAS and NT-pro BNP cannot be used as a sensitive marker for underlying cardiovascular abnormalities in patients with OSAS.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17892929</pmid><doi>10.1016/j.rmed.2007.07.023</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2008-01, Vol.102 (1), p.134-142
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_miscellaneous_70092364
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Agreements
Biological and medical sciences
Biomarkers - blood
BNP
Body mass index
Confidence intervals
Female
Females
Heart disease
Heart Diseases - complications
Heart Diseases - metabolism
Heart failure
Hormone replacement therapy
Humans
Male
Medical sciences
Middle Aged
Multivariate analysis
Natriuretic Peptide, Brain - blood
Natriuretic peptides
NT-proBNP
Obesity
OSAS
Peptide Fragments - blood
Peptides
Pneumology
Polysomnography - methods
Predictive Value of Tests
Pulmonary/Respiratory
Regression Analysis
Respiratory system : syndromes and miscellaneous diseases
Sleep
Sleep apnea
Sleep Apnea, Obstructive - blood
Sleep Apnea, Obstructive - therapy
title NT-proBNP is not elevated in patients with obstructive sleep apnoea
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T05%3A34%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NT-proBNP%20is%20not%20elevated%20in%20patients%20with%20obstructive%20sleep%20apnoea&rft.jtitle=Respiratory%20medicine&rft.au=H%C3%BCbner,%20Ralf-Harto&rft.date=2008-01-01&rft.volume=102&rft.issue=1&rft.spage=134&rft.epage=142&rft.pages=134-142&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2007.07.023&rft_dat=%3Cproquest_cross%3E70092364%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035046491&rft_id=info:pmid/17892929&rft_els_id=S0954611107003290&rfr_iscdi=true